期刊文献+

52例骨髓增生异常综合征的细胞形态学分析 被引量:2

下载PDF
导出
摘要 目的分析骨髓增生异常综合征(MDS)的细胞形态学特点和病态造血对其诊断的价值。方法对52例经确诊MDS病例采取骨髓、外周血涂片,进行Wright-Giemsa染色和细胞形态学分析,为形态学诊断提供特征性诊断依据。结果 MDS病例的骨髓粒、红、巨三系均存在不同程度的病态造血改变,粒系表现为类巨变、Auer小体、双核、假Pelger-Huet核畸形、核浆发育失衡、胞质颗粒减少或缺失、黄沙样颗粒、中性粒核分叶过多或过少;红系表现为类巨变、多核和奇数核、核出芽和核畸形;巨核系表现为淋巴样小巨核、单圆核、多圆核等。结论细胞形态学是MDS的最重要、基础的诊断手段,部分病例在早期需结合其他检测技术提高诊断的准确率。
作者 胡昊
出处 《国际检验医学杂志》 CAS 2013年第20期2773-2774,共2页 International Journal of Laboratory Medicine
  • 相关文献

参考文献9

二级参考文献34

  • 1金洁.骨髓增生异常综合征[J].诊断学理论与实践,2005,4(5):426-429. 被引量:1
  • 2Heaney ML, Gold DW. Myelodysplasia. N Engl J Med, 1999; 340 : 1649 - 1660.
  • 3Valent P, Horny HP, Bennett JM, et al. Definitions and standards in the diagnosis and treatdment of the myelodysplastic syndromes: consensus statements and report from a working conference. Leuk Res, 2007 ;31:727 -736.
  • 4Nimer SD. Myelodysplastic Syndromes. Blood, 2008 ; 111 : 4841 -4851.
  • 5Wells DA, Benesch M, Loken MR, et al. Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelo- dysplastic syndrome correlates with the IPSS and with the outcome after hematopoietic stem cell transplantation. Blood, 2003;102:394 - 403.
  • 6Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood, 2002 ; 100:2292 - 2302.
  • 7Jaffe ES, Harris NL, Stein H, et al. Tumours of Haematopoietic and Lymphoid Tissues. In: World Health Organization Classification of Tumours. Lyon, France: IARC Press. 2001:60-73.
  • 8Greenberg P, Cox C, LeBeau MM, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood, 1997 ; 89 : 2097 -2088.
  • 9Craig FE, Foon KA. Flow cytometric immunophenotyping for hematologic neoplasms. Blood, 2008 ; 111 : 3941 - 3967.
  • 10Maynadie M, Picard F, Husson B, et al. Immunophenotypic clustering of myelodysplastic syndromes. Blood, 2002; 100:2349 - 2356.

共引文献48

同被引文献22

  • 1赵广玲,许洪志,黄敏,李元堂,武焕玲,李建峰,马春燕.骨髓增生异常综合征和再生障碍性贫血患者骨髓原始细胞免疫表型分析[J].山东大学学报(医学版),2009,47(2):53-57. 被引量:4
  • 2陆再英,钟南山.内科学[M].7版.北京:人民卫生出版社,2008:274-284.
  • 3Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of tumours of haematopoietic and lymphoid tissues [ M ]. Lyon: IARC Press, 2008: 88.
  • 4Takanashi M, Kadono Y, Tabata Y, et al. Successful immunosupressive therapy for a patient with hypoplasitic myelodysplastic syndrome [ J ] Rinsho Ketsueki, 1999, 40 ( 10 ) : 1093-1099.
  • 5Sevilla DW, Emmons FN, Colovai AI, et al. Hematogones are markedly reduced in pediatric acquired aplastic anemia: multiparametric flow cytometric analysis [ J ]. Leuk Lymphoma, 2009, 50(12) : 1951-1957.
  • 6Tamai Y, Takami H, Nakahata R, et at. Hematolocal characteristics of hypoplastic MDS patients with chromosomal abnormalitilies,who had been followed for aplastic anemia with normal karyotypes [J]. Rinsho Ketueki, 1997, 38 (12) : 1243- 1248.
  • 7Maciejewski JP, Selleri C. Evolution of clonal cytogenetic abnormalities in aplastic anemia [ J 1. Leuk Lymphoma,2004, 45 ( 3 ) : 433-440.
  • 8Bejar R, Stevenson K, Abdel-Wahab O, et al. Clinical effect of point mutations in myelodysplastic syndromes [ J ]. N Engl J Med, 2011, 364 ( 26 ) : 2496-2506.
  • 9Kracmarova A, Cermak J, Brdicka R, et al. High expression of ERCC 1, FLT1, NME4 and PCNA associated with poor prognosis and advanced stages in myelodysplastic syndrome [ J]. luk Lymphoma, 2008, 49 ( 7 ) : 1297-1305.
  • 10Matsui WH, Brodsky RA, Smith BD, et al. Quantitative analysis of bone marrow CD34 ceils in aplastic anemia and hypoplastic myelodysplastic syndromes [ J ]. Leukemia, 2006, 20 ( 3 ) : 458- 462.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部